@article{fe706732afab4a87863001d8eccb5c5a,
title = "The relationship between alcohol use and dementia in adults aged more than 60 years: a combined analysis of prospective, individual-participant data from 15 international studies",
abstract = "Aim: To synthesize international findings on the alcohol–dementia relationship, including representation from low- and middle-income countries. Methods: Individual participant data meta-analysis of 15 prospective epidemiological cohort studies from countries situated in six continents. Cox regression investigated the dementia risk associated with alcohol use in older adults aged over 60 years. Additional analyses assessed the alcohol–dementia relationship in the sample stratified by sex and by continent. Participants included 24 478 community dwelling individuals without a history of dementia at baseline and at least one follow-up dementia assessment. The main outcome measure was all-cause dementia as determined by clinical interview. Results: At baseline, the mean age across studies was 71.8 (standard deviation = 7.5, range = 60–102 years), 14 260 (58.3%) were female and 13 269 (54.2%) were current drinkers. During 151 636 person-years of follow-up, there were 2124 incident cases of dementia (14.0 per 1000 person-years). When compared with abstainers, the risk for dementia was lower in occasional [hazard ratio (HR) = 0.78; 95% confidence interval (CI) = 0.68–0.89], light–moderate (HR = 0.78; 95% CI = 0.70–0.87) and moderate–heavy drinkers (HR = 0.62; 95% CI = 0.51–0.77). There was no evidence of differences between life-time abstainers and former drinkers in terms of dementia risk (HR = 0.98; 95% CI = 0.81–1.18). In dose–response analyses, moderate drinking up to 40 g/day was associated with a lower risk of dementia when compared with lif-time abstaining. Among current drinkers, there was no consistent evidence for differences in terms of dementia risk. Results were similar when the sample was stratified by sex. When analysed at the continent level, there was considerable heterogeneity in the alcohol–dementia relationship. Conclusions: Abstinence from alcohol appears to be associated with an increased risk for all-cause dementia. Among current drinkers, there appears to be no consistent evidence to suggest that the amount of alcohol consumed in later life is associated with dementia risk.",
keywords = "Alcohol, cross-national comparison, dementia, epidemiology, individual participant data meta-analysis, older adults",
author = "{Collaborators from the Cohort Studies of Memory in an International Consortium (COSMIC)} and Louise Mewton and Rachel Visontay and Nicholas Hoy and Lipnicki, {Darren M.} and Matthew Sunderland and Lipton, {Richard B.} and Ma{\"e}lenn Guerchet and Karen Ritchie and Jenna Najar and Nikolaos Scarmeas and Kim, {Ki Woong} and {Riedel Heller}, Steffi and {van Boxtel}, Martin and Erin Jacobsen and Henry Brodaty and Anstey, {Kaarin J.} and Mary Haan and Marcia Scazufca and Elena Lobo and Sachdev, {Perminder S.}",
note = "Funding Information: Funding for COSMIC comes from the National Institute on Aging of the National Institutes of Health under Award Number RF1AG057531. HELIAD funding: IIRG‐09‐133014 from the Alzheimer{\textquoteright}s Association, 189 10276/8/9/2011 from the NSRF‐EU program Excellence Grant (ARISTEIA) (which is co‐funded by the European Social Fund and Greek National resources) and ΔΥ2β/οικ.51657/14.4.2009 from the Ministry for Health and Social Solidarity (Greece). KLOSCAD funding: a grant from the Korean Health Technology R&D Project, Ministry of Health and Welfare, Republic of Korea (grant no. HI09C1379). H70 funding: the study was financed by grants from the Swedish state under the agreement between the Swedish government and the county councils (the ALF‐agreement; ALF 716681), Stena Foundation, Swedish Research Council (11267, 2005‐8460, 2007‐7462, 2012‐5041, 2015‐02830, 2019‐01096, 2013‐8717, NEAR 2017‐00639), Swedish Research Council for Health, Working Life and Welfare (2004‐0145, 2006‐0596, 2008‐1111, 2010‐0870, 2013‐1202, 2018‐00471, 2001‐2646, 2003‐0234, 2004‐0150, 2006‐0020, 2008‐1229, 2012‐1138, AGECAP 2013‐2300, 2013‐2496), Konung Gustaf V{\textquoteright}s och Drottning Victorias Frimurarestiftelse, Hj{\"a}rnfonden (FO2014‐0207, FO2016‐0214, FO2018‐0214, FO2019‐0163) Alzheimerfonden, Eivind och Elsa K:son Sylvans stiftelse, The Alzheimer{\textquoteright}s Association Zenith Award (ZEN‐01‐3151), The Alzheime{\textquoteright}s Association Stephanie B. Overstreet Scholars (IIRG‐00‐2159), The Bank of Sweden Tercentenary Foundation, Stiftelsen S{\"o}derstr{\"o}m‐K{\"o}nigska Sjukhemmet, Stiftelsen f{\"o}r Gamla Tj{\"a}narinnor, Handlanden Hjalmar Svenssons Forskningsfond, Systembolagets alkoholforskningsr{\aa}d (CAN), Swedish Research Council for Health, Working Life and Welfare (2017‐1604). LEILA75+ funding: the Interdisciplinary Centre for Clinical Research at the University of Leipzig (Interdisziplin{\"a}res Zentrum f{\"u}r Klinische Forschung/IZKF; grant 01KS9504). The SPAH study was funded by Wellcome Trust, UK (GR066133MA); Conselho Nacional de Desenvolvimento Cient{\'i}fico e Tecnol{\'o}gico, Brazil (CNPQ) partially supported MS (307579/2019‐0). ZARADEMP funding: supported by grants from the Fondo de Investigaci{\'o}n Sanitaria, Instituto de Salud Carlos III, Spanish Ministry of Economy and Competitiveness, Madrid, Spain (grants 94/1562, 97/1321E, 98/0103, 01/0255, 03/0815, 06/0617, G03/128) and the Fondo Europeo de Desarrollo Regional (FEDER) of the European Union and Gobierno de Arag{\'o}n, Group #19. COSMIC management: the head of COSMIC is Perminder S. Sachdev, and the Study Co‐Ordinator is Darren M. Lipnicki. The Research Scientific Committee leads the scientific agenda of COSMIC and provides ongoing support and governance; it is composed of member study leaders (in alphabetical order): Kaarin Anstey, Carol Brayne, Henry Brodaty, Liang‐Kung Chen, Erico Costa, Michael Crowe, Oscar Del Brutto, Ding Ding, Jacqueline Dominguez, Mary Ganguli, Antonio Guaita, Ma{\"e}lenn Guerchet, Oye Gureje, Jacobijn Gussekloo, Mary Haan, Hugh Hendrie, Ann Hever, Ki‐Woong Kim, Seb Koehler, Murali Krishna, Linda Lam, Bagher Larijani, Richard Lipton, Juan Llibre‐Rodriguez, Antonio Lobo, Richard Mayeux, Kenichi Meguro, Vincent Mubangizi, Toshiharu Ninimiya, Stella‐Maria Paddick, Maria Skaalum Petersen, Ng Tze Pin, Steffi Riedel‐Heller, Karen Ritchie, Kenneth Rockwood, Nikolaos Scarmeas, Marcia Scazufca, Suzana Shahar, Xiao Shifu, Kumagai Shuzo, Ingmar Skoog and Yuda Turana. Additional member study leaders: Marie‐Laure Ancelin, Mindy Katz, Martin van Boxtel, Iraj Nabipour, Pierre‐Marie Preux, Perminder Sachdev, Nicole Schupf, Richard Walker. COSMIC NIH grant investigators: Perminder Sachdev: Scientia Professor of Neuropsychiatry; Co‐Director, Centre for Healthy Brain Ageing (CHeBA), UNSW Sydney; Director, Neuropsychiatric Institute, Prince of Wales Hospital, Sydney, Australia; Mary Ganguli: Professor of Psychiatry, Neurology, and Epidemiology, University of Pittsburgh; Ronald Petersen: Professor of Neurology, Director, Mayo Clinic Alzheimer{\textquoteright}s Disease Research Center and the Mayo Clinic Study of Aging; Richard Lipton: Edwin S. Lowe Professor and Vice Chair of Neurology, Albert Einstein College of Medicine; Karen Ritchie: Professor and Director of the Neuropsychiatry Research Unit of the French National Institute of Research (INSERM U1061); Ki‐Woong Kim: Professor of Brain and Cognitive Sciences, Director of National Institute of Dementia of Korea; Louisa Jorm: Director, Centre for Big Data Research in Health and Professor, Faculty of Medicine, UNSW Sydney, Australia; Henry Brodaty: Scientia Professor of Ageing and Mental Health; Co‐Director, Centre for Healthy Brain Ageing (CHeBA), UNSW Sydney; Director, Dementia Collaborative Research Centre (DCRC); Senior Consultant, Old Age Psychiatry, Prince of Wales Hospital. Open access publishing facilitated by University of New South Wales, as part of the Wiley ‐ University of New South Wales agreement via the Council of Australian University Librarians; EPIDEMCA: French National Agency (ANR) grant (ANR‐ 09‐MNPS‐009‐01 grant); AXA Research Fund (grant 2012 – Project – Public Health Institute (Inserm) – PREUX Pierre‐Marie); and the Limoges University Hospital through its APREL scheme. Dr Mewton was funded by a Dementia Centre for Research Collaboration Research Grant (RG180842‐A). Open access publishing facilitated by University of New South Wales, as part of the Wiley ‐ University of New South Wales agreement via the Council of Australian University Librarians. Publisher Copyright: {\textcopyright} 2022 The Authors. Addiction published by John Wiley & Sons Ltd on behalf of Society for the Study of Addiction.",
year = "2023",
month = mar,
doi = "10.1111/add.16035",
language = "English (US)",
volume = "118",
pages = "412--424",
journal = "Addiction",
issn = "0965-2140",
publisher = "Wiley-Blackwell",
number = "3",
}